Chiba, Japan

Hideki Kozono

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Toray Industries, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideki Kozono. Retrieved from https://idiyas.com/inventor/hideki-kozono-tw3vd2df

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile




Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hideki Kozono in Diabetes Treatment

Introduction

Hideki Kozono is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of metabolic disorders. His innovative work focuses on developing therapeutic agents for diabetes, obesity, dyslipidemia, and metabolic syndrome.

Latest Patents

Kozono holds a patent for a therapeutic or prophylactic agent that comprises a benzylamine derivative or a pharmaceutically acceptable acid addition salt thereof. This patent outlines a method for treating or preventing diabetes, obesity, dyslipidemia, or metabolic syndrome by administering an effective amount of a benzylamine derivative. The formula includes various alkyl groups and halogen atoms, showcasing the complexity and potential effectiveness of his invention.

Career Highlights

Kozono is associated with Toray Industries, Inc., where he continues to work on innovative solutions in the pharmaceutical field. His dedication to research and development has positioned him as a key figure in advancing treatments for metabolic disorders.

Collaborations

He collaborates with esteemed colleagues such as Ko Hasebe and Satoru Yoshikawa, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Hideki Kozono's work exemplifies the impact of innovative thinking in the medical field. His contributions to diabetes treatment through his patented methods highlight the importance of research and collaboration in developing effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…